Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO MAP 2022 | Increasing the recruitment of high endothelial venules (HEVs) into the tumor

Jean-Philippe Girard • 13 Oct 2022
ESMO MAP 2022
General

Jean-Philippe Girard, PhD, CNRS-Université de Toulouse III, Toulouse, France, discusses the development of methods to increase the recruitment of high endothelial venules (HEVs) to the tumor site to improve the efficacy of immunotherapy. This interview took place at the Molecular Analysis for Precision oncology (MAP) Congress 2022 in Amsterdam, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Jean-Philippe Girard

1:22
The entry of lymphocytes into the tumor via high endothelial venules
Jean-Philippe Girard • 13 Oct 2022
4:17
HEVs and lymphocyte recruitment in tumors in response to immune checkpoint blockade
Jean-Philippe Girard • 13 Oct 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals